Notably, in the groups not treated with IMQ, the co-occurrence of NASH moderately increased the expression of some genes, such as Il17a and Il36g (Figure 4), although the changes were not significant owing to the large variation in the data. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.